化浊和胃散结汤联合FOLFOX方案治疗晚期胃癌36例

来源 :中国中西医结合消化杂志 | 被引量 : 0次 | 上传用户:mail1631987
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
[目的]观察化浊和胃散结汤联合FOLFOX方案治疗晚期胃癌的疗效。[方法]将66例患者随机分为2组,治疗组36例,采用中药化浊和胃散结汤联合FOLFOX方案治疗,对照组30例,单纯采用FOLFOX方案化疗。[结果]治疗组和对照组有效率分别为72.22%和46.67%,差异有统计学意义(P<0.05);治疗组半年生存率和1年生存率分别为75.00%和47.22%,对照组半年生存率和1年生存率分别为46.67%和23.33%。2组半年生存率及1年生存率比较,差异均有统计学意义(P<0.05)。[结论]化浊和胃散结汤联合FOLFOX方案治疗晚期胃癌能延长患者生存期。 [Objective] To observe the curative effect of Huazhuo Weisujie Decoction combined with FOLFOX regimen in the treatment of advanced gastric cancer. [Methods] 66 patients were randomly divided into two groups, the treatment group of 36 cases, using the traditional Chinese medicine Huazhuo Wei San Sanjie Decoction combined with FOLFOX regimen, the control group of 30 cases, simple treatment with FOLFOX regimen. [Results] The effective rates of the treatment group and the control group were 72.22% and 46.67%, respectively, with significant difference (P <0.05). The half-year and 1-year survival rates of the treatment group and the control group were 75.00% and 47.22% The survival rate and 1-year survival rate were 46.67% and 23.33% respectively. The 2-year survival rates and 1-year survival rates of two groups were significantly different (P <0.05). [Conclusion] Huazhuo Weiseljie Decoction combined with FOLFOX regimen can prolong the survival of patients with advanced gastric cancer.
其他文献
谢强教授系全国第三批、第四批老中医药专家学术经验继承工作指导老师、博士生导师、江西省名中医,临证近40年.他精研经典,归纳诸家,总结形成了独到的治未病护嗓经验,即:一个
期刊
期刊
患者,35岁,因白带增多3个月,进行性腹痛半月余入院。3个月前无明显诱因下出现白带增多,带血丝,有异味。一个月前患者症状加重,病检为宫颈粘膜慢性炎。并出现腹胀、腹痛进行性
期刊
期刊
[目的]探讨老年人服用非甾体抗炎药致上消化道出血的风险。[方法]回顾性分析2003年8月至2009年8月收治的因服用非甾体抗炎药致上消化道出血老年患者60例的临床资料。[结果]经
目的:探讨VEGF和nm23-H1基因表达水平与周围型肺癌的病理生理学特征和CT征象之间的关系。方法:回顾性分析确诊的47例周围型肺癌患者CT表现,同时采用免疫组化方法(LSAB法)检测
期刊
随着新课程改革的不断深入,如何转变传统教学观念让学生真正成为学习的主人,如何在有限的课堂彰显科学的教育教学理念变得越来越重要。笔者就综合实践课程教学谈谈自己的体会
期刊